Standard Immunosuppressive Therapy Combined With Romiplostim N01 as First-line Treatment for Severe Aplastic Anemia

Recruiting now · Phase 2

Conditions studied: Aplastic Anemia, TPO Receptor Agonists

In brief

This prospective, single center, single-arm study aims to evaluate the efficacy and safety of anti-human T lymphocyte porcine immunoglobulin (p-ALG) in combination with cyclosporine and Romiplostim in treating severe aplastic anemia (SAA). It will include 48 patients with newly diagnosed SAA.

Key facts

Study ID

NCT06613880

Run by

Institute of Hematology & Blood Diseases Hospital, China

People needed

48

Starts

2024-10-24

Expected to finish

2026-09-30

Last updated by the study team

2024-12-04

Who can join

Age: 12 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age ≥ 12 years
• Diagnosis of severe or very severe aplastic anemia
• Patients are unconditionally or unacceptable undergoing allogeneic hematopoietic stem cell transplantation
• ECOG performance status ≤2
• Willing and able to comply with the requirements for this study and written informed consent.

You may not qualify if…

• Received > 4 weeks of TPO-RA drug before treatment
• Received > 4 weeks of immunosuppressive therapy before treatment
• History of thromboembolic disease
• Intolerance to Romiplostim N01 or cyclosporine
• Allergy to ALG
• Presence of uncontrolled active infection
• Presence of uncontrolled hypertension (≥140/90mmHg), diabetes mellitus (fasting blood glucose≥ 7.0 mmol/L or random blood glucose ≥ 11.1 mmol/L)
• Abnormal liver and kidney function: Aspartate Transaminase (AST) or Alanine Transaminase (ALT) > 3 ULN, creatinine ≥ 2.5 ULN
• History of chemoradiotherapy for malignant solid tumors
• History of other systemic serious illnesses
• Females who are pregnant/lactating or need pregnancy
• Patients considered to be ineligible for the study by the investigator for reasons other than the above

Where it is running

• Regenerative Medicine Center and Red Blood Cell Disorders Center — Tianjin, Tianjin Municipality, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.